Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220005959 220002320 1.8 null Curative (C) 2014-03-08 2014-08-14 null Y N 220029332 NOT MATCHED
220005960 220011296 0 null Curative (C) 2016-09-22 2016-09-22 Nilotinib 02 N 220029334 NILOTINIB
220005961 220011296 1.61 null Curative (C) 2013-11-22 2013-11-22 FLAG + Idarubicin N N 220029334 FLAG + IDARUBICIN
220005962 220011296 1.57 91.3 Curative (C) 2017-12-13 2017-12-13 AML 19 TRIAL null null 220029334 AML19 TRIAL
220005963 220002321 1.72 null Disease modification (D) 2018-05-19 2018-05-19 Nilotinib N N 220029339 NILOTINIB
220005964 220002321 1.68 105.5 Curative (C) 2015-12-06 2015-12-09 AML 19 TRIAL Y null 220029339 AML19 TRIAL
220005965 220002321 1.56 104.5 Curative (C) 2017-07-08 2017-07-08 AML 19 TRIAL 1 N 220029339 AML19 TRIAL
220005966 220002322 null 0 Disease modification (D) 2016-03-02 2016-03-03 Nilotinib N N 220029347 NILOTINIB
220005967 220002322 0 0 Curative (C) 2013-01-29 2013-01-29 FBC Conditionining N null 220029347 NOT MATCHED
220005968 220002322 1.8 72.1 Curative (C) 2017-07-10 2017-07-11 AML 19 TRIAL Y N 220029347 AML19 TRIAL
220005969 220002323 1.61 106.2 Curative (C) 2016-09-22 2016-09-22 AML 19 TRIAL Y N 220029355 AML19 TRIAL
220005970 220002323 1.65 97.4 Curative (C) 2016-07-01 2016-07-01 AML 19 TRIAL Y N 220029355 AML19 TRIAL
220005972 220002324 null 116.6 Curative (C) 2013-04-22 2013-04-22 AML 19 TRIAL N N 220029359 AML19 TRIAL
220005973 220002324 1.6 14.2 Curative (C) 2018-01-21 2019-02-28 Quizartinib (AC220) 1 N 220029359 NOT MATCHED
220005974 220002324 null null null 2013-09-29 2013-10-02 Nilotinib N N 220029359 NILOTINIB
220005975 220002325 null 0 Adjuvant (A) 2013-10-16 2013-10-17 Nilotinib N N 220029364 NILOTINIB
220005976 220002326 1.63 72.1 Curative (C) null 2013-03-21 FLAG + Idarubicin N N 220029366 FLAG + IDARUBICIN
220005977 220002327 1.82 0 Not known (9) 2015-10-30 2015-10-30 Nilotinib 02 N 220029367 NILOTINIB
220005978 220002328 1.77 22.7 Curative (C) 2015-10-25 2015-10-29 APML Consolidation II ATRA,Idarubicin 02 N 220029368 NOT MATCHED
220005979 220002329 0 null Curative (C) 2014-09-29 2014-10-03 Nilotinib N N 220029369 NILOTINIB
220005980 220011301 null 56.2 Curative (C) 2017-12-06 2017-12-06 AML 19 TRIAL N N 220029372 AML19 TRIAL
220005981 220011301 1.73 73 Disease modification (D) 2017-04-17 2017-04-23 FLAG + Idarubicin null null 220029372 FLAG + IDARUBICIN
220005982 220002330 1.67 106 Curative (C) 2016-04-14 2016-04-14 AML 19 TRIAL Y N 220029376 AML19 TRIAL
220005983 220002331 1.75 83.7 Curative (C) 2015-10-17 2015-10-18 AML 19 TRIAL N N 220029381 AML19 TRIAL
220005984 220002331 null 78.5 Disease modification (D) 2017-09-01 2017-09-01 Nilotinib N N 220029381 NILOTINIB
220005985 220002331 1.77 76.4 Curative (C) 2013-03-16 2013-03-16 AML 19 TRIAL Y N 220029381 AML19 TRIAL
220005986 220002332 1.66 76.7 Curative (C) 2017-08-26 2017-08-26 AML 19 TRIAL 01 null 220029389 AML19 TRIAL
220005987 220002333 null 10 Curative (C) 2013-01-14 2013-02-15 CYTARABINE + Hydroxycarbamide 2 N 220029391 NOT MATCHED
220005988 220002333 1.87 107 Curative (C) 2015-04-30 2015-05-01 AML 19 TRIAL N N 220029391 AML19 TRIAL
220005989 220002334 1.63 75 Curative (C) 2017-11-05 2017-11-09 FLAG + Idarubicin 2 N 220029393 FLAG + IDARUBICIN
220005990 220002334 1.6 108 Curative (C) 2017-05-27 2017-05-30 AML 19 TRIAL 01 null 220029393 AML19 TRIAL
220005991 220002335 1.73 55 Curative (C) 2013-02-28 2013-02-28 FLAG + Idarubicin Y N 220029397 FLAG + IDARUBICIN
220005992 220002335 1.67 101 Curative (C) null 2014-12-27 AML Interim Guidelines FLAG-Ida N N 220029397 FLAG + IDARUBICIN
220005993 220002336 null 61.3 Curative (C) 2017-01-21 2017-01-25 APML Cons ATO + ATRA 2 N 220029400 NOT MATCHED
220005994 220011306 1.64 63.6 Curative (C) 2016-02-10 2016-02-10 AML 19 TRIAL N N 220029403 AML19 TRIAL
220005995 220011306 0 0 Curative (C) 2014-10-05 2014-10-19 Nilotinib 02 N 220029403 NILOTINIB
220005996 220002337 1.7 94.2 Curative (C) 2017-08-11 2017-08-11 FLAG + Idarubicin N N 220029408 FLAG + IDARUBICIN
220005997 220002337 0 0 Disease modification (D) 2016-05-13 2016-08-15 Nilotinib 02 N 220029408 NILOTINIB
220005998 220002337 null 0 Disease modification (D) 2014-07-13 2014-07-13 Nilotinib 2 N 220029408 NILOTINIB
220005999 220018791 1.59 98 Curative (C) 2013-01-24 2013-02-04 Nilotinib 2 N 220029416 NILOTINIB
220006000 220002338 null 79.3 Curative (C) 2015-09-30 2015-09-30 AML Interim Guidelines FLAG-Ida N N 220029420 FLAG + IDARUBICIN
220006001 220011308 1.83 60.3 Disease modification (D) 2013-05-23 2013-05-24 AML 19 TRIAL Y N 220029423 AML19 TRIAL
220006002 220011308 1.62 null Curative (C) 2017-04-13 2017-04-22 AML Interim Guidelines FLAG-Ida N N 220029423 FLAG + IDARUBICIN
220006003 220002339 null null null 2015-03-31 2015-03-31 FLAG + Idarubicin null N 220029425 FLAG + IDARUBICIN
220006004 220002339 1.84 78.5 Curative (C) 2013-02-28 2013-03-04 AML 19 TRIAL Y N 220029425 AML19 TRIAL
220006005 220002340 1.56 77 Curative (C) 2018-04-03 2018-04-03 Nilotinib N N 220029427 NILOTINIB
220006006 220002340 null 85 Disease modification (D) 2013-03-30 2013-04-03 AML 19 TRIAL Y N 220029427 AML19 TRIAL
220006007 220002340 1.78 77.5 Curative (C) 2014-11-11 2014-11-21 FLAG + Idarubicin N N 220029427 FLAG + IDARUBICIN
220006008 220002340 1.7 0 Curative (C) 2016-12-15 2016-12-15 Nilotinib null N 220029427 NILOTINIB
220006009 220002341 0 85 Disease modification (D) 2016-04-28 2016-04-28 Nilotinib 2 N 220029438 NILOTINIB